SCHEMBL7267289

SCHEMBL7267289

[c]1ncc(-c2ccco2)c(-c2ccc3ccccc3n2)c1-c1cccs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
RAB9A P51151 6/20 0.51
KDM4E B2RXH2 6/20 0.51
NPC1 O15118 5/20 0.51
HSD17B10 Q99714 4/20 0.51
TOP1 P11387 1/20 0.43
ADORA2A P29274 3/20 0.41
ADORA2B P29275 2/20 0.41
ADORA1 P30542 2/20 0.41
POLB P06746 3/20 0.40
DCTPP1 Q9H773 1/20 0.40
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 3/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39
MAPK10 P53779 1/20 0.39
STAT3 P40763 1/20 0.37
ATM Q13315 1/20 0.36
F2 P00734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7268425 0.74 ALDH1A1 (0.39) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL30021580 0.72 RAB9A (0.96) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL1238527 0.70 RAB9A (1.00) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL30950703 0.70 RAB9A (1.00) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL3344845 0.70 KDM4E (0.55) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL7269678 0.68 ALDH1A1 (0.48) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL19491827 0.65 RAB9A (0.81) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL28162212 0.65 RAB9A (0.75) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL5567841 0.64 ALDH1A1 (0.46) ALDH1A1RAB9AKDM4ENPC1HSD17B10
SCHEMBL521943 0.64 ALDH1A1 (0.62) ALDH1A1RAB9AKDM4ENPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0361341-A2 Therapeutics for aids based on inhibitors of HIV protease MILES INC. (US) 1990-04-04 EP claimed
EP-0361341-A2 Therapeutics for aids based on inhibitors of HIV protease MILES INC. (US) 1990-04-04 EP disclosed